Position in IBRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$135,821,150
+$103,238,859 QoQ
Shares Held
17,708,103
+7.6% QoQ
Ownership
1.69%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 9.787299068680593.ToString("F0")%
Shared 0.010164838097.ToString("F0")%
None 90.2025360932224.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,287,966,567 across 421 Biotechnology names. IBRX ranks #48 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in IBRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $135,821,150 | 17,708,103 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $32,582,291 | 16,455,703 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $27,836,899 | 11,315,813 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $20,105,094 | 7,615,566 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $22,827,542 | 7,583,901 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $25,050,001 | 9,785,157 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $32,194,591 | 8,654,460 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $49,700,808 | 7,864,052 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $76,169,567 | 14,184,277 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $47,543,963 | 9,470,909 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,596,110 | 2,719,592 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,720,716 | 2,777,236 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,822,659 | 2,649,813 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $34,151,778 | 6,736,051 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $33,047,175 | 6,649,331 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $6,950,909 | 1,868,524 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $37,925,316 | 6,760,306 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $37,789,492 | 6,215,377 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $51,795,177 | 5,317,780 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $59,884,893 | 4,193,620 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $55,375,259 | 2,332,572 | Shares | Defined | 2021-07-09 | |
| No filing history on record for this holder in this stock. | ||||||